StarZero All shows Try the podcast clipper →

AXVS-101

1 statements across 1 episodes · 1 bullish · 0 bearish · 1 people on the record · first statement Feb 28, 2019 by Koki Hirasaki · across every show →

Everything said about AXVS-101, oldest first

Feb 28, 2019 positive
Assertion Supported
Hirasaki: AveXis acquisition gave Novartis an AAV9 platform for gene delivery
“So the lead asset AXVS- one-on-one it, you know, certainly is going to be probably best in class for SMA, but it also gave Novartis an AAV nine vector platform that it could use to deliver other gene therapies.”
Koki Hirasaki Feb 28, 2019 ▶ 5:36 What’s with All the Bio M&A in 2019?: A Quick Take
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 1,000 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.

Try the podcast clipper Learn more